儿童院外心脏骤停的高级气道管理:系统评价与网状Meta分析
该系统评价与网状Meta分析检索4个数据库至2022年11月,纳入5项研究(1项临床试验和4项严格校正混杂的队列研究),共4852例年龄<18岁的院外心脏骤停患儿,比较球囊面罩通气、气管插管和声门上气道装置对出院或心脏骤停后1个月生存及良好神经功能结局的影响。与气管插管相比,球囊面罩通气与生存相关(RR 0.44,95%CI 0.25-0.77;证据确定性极低);其他比较与生存无显著关联,任何比较与良好神经功能结局均无显著关联。排序分析中生存和良好神经功能结局的疗效排序均为球囊面罩通气>声门上气道>气管插管。作者结论认为,尽管证据来自观察性研究且确定性低至极低,院前高级气道管理未改善儿童院外心脏骤停结局。
要点
- 在儿童院外心脏骤停中,与气管插管相比,球囊面罩通气与生存相关(RR 0.44,95%CI 0.25-0.77),证据确定性极低。
- 声门上气道与球囊面罩通气相比(RR 0.62,95%CI 0.33-1.15;低确定性)、气管插管与声门上气道相比(RR 0.71,95%CI 0.39-1.32;极低确定性),与生存均无显著关联。
- 任何气道比较与良好神经功能结局均无显著关联:气管插管 vs 球囊面罩通气 RR 0.33(95%CI 0.11-1.02)、声门上气道 vs 球囊面罩通气 RR 0.50(95%CI 0.14-1.80)、气管插管 vs 声门上气道 RR 0.66(95%CI 0.18-2.46),均为极低确定性。
- 排序分析中,生存和良好神经功能结局的疗效排序均为球囊面罩通气>声门上气道>气管插管。
- 作者结论认为,院前高级气道管理未改善儿童院外心脏骤停结局,现有证据确定性低至极低。
适用人群与场景
- 年龄<18岁的院外心脏骤停患儿,接受院前复苏。
研究设计与关键结果
- 系统评价与网状Meta分析,纳入5项研究(1项临床试验和4项严格校正混杂的队列研究),共4852例年龄<18岁的院外心脏骤停患儿。
- 与气管插管相比,球囊面罩通气与生存相关(RR 0.44,95%CI 0.25-0.77;证据确定性极低)。
- 声门上气道 vs 球囊面罩通气与生存无显著关联(RR 0.62,95%CI 0.33-1.15;低确定性)。
- 气管插管 vs 声门上气道与生存无显著关联(RR 0.71,95%CI 0.39-1.32;极低确定性)。
- 气管插管 vs 球囊面罩通气与良好神经功能结局无显著关联(RR 0.33,95%CI 0.11-1.02;极低确定性)。
- 声门上气道 vs 球囊面罩通气与良好神经功能结局无显著关联(RR 0.50,95%CI 0.14-1.80;极低确定性)。
- 气管插管 vs 声门上气道与良好神经功能结局无显著关联(RR 0.66,95%CI 0.18-2.46;极低确定性)。
- 排序分析中,生存和良好神经功能结局的疗效排序均为球囊面罩通气>声门上气道>气管插管。
证据类型、等级与局限
- 证据类型:系统评价与网状Meta分析,纳入随机对照试验和观察性研究(1项临床试验和4项队列研究)。
- 证据确定性采用GRADE方法评价:生存比较中球囊面罩通气 vs 气管插管为极低确定性,声门上气道 vs 球囊面罩通气为低确定性,气管插管 vs 声门上气道为极低确定性;良好神经功能结局所有比较均为极低确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,尽管证据来自观察性研究且确定性低至极低,院前高级气道管理未改善儿童院外心脏骤停结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Although airway management is important in pediatric resuscitation, the effectiveness of bag-mask ventilation (BMV) and advanced airway management (AAM), such as endotracheal intubation (ETI) and supraglottic airway (SGA) devices, for prehospital resuscitation of pediatric out-of-hospital cardiac arrest (OHCA) remains unclear. We aimed to determine the efficacy of AAM during prehospital resuscitation of pediatric OHCA cases.
METHODS: We searched four databases from their inception to November 2022 and included randomized controlled trials and observational studies with appropriate adjustments for confounders that evaluated prehospital AAM for OHCA in children aged <18 years in quantitative synthesis. We compared three interventions (BMV, ETI, and SGA) via network meta-analysis using the GRADE Working Group approach. The outcome measures were survival and favorable neurological outcomes at hospital discharge or 1 month after cardiac arrest.
RESULTS: Five studies (including one clinical trial and four cohort studies with rigorous confounding adjustment) involving 4852 patients were analyzed in our quantitative synthesis. Compared with ETI, BMV was associated with survival (relative risk [RR] 0.44 [95% confidence intervals (CI) 0.25-0.77]) (very low certainty). There were no significant association with survival in the other comparisons (SGA vs. BMV: RR 0.62 [95% CI 0.33-1.15] [low certainty], ETI vs. SGA: RR 0.71 [95% CI 0.39-1.32] [very low certainty]). There was no significant association with favorable neurological outcomes in any comparison (ETI vs. BMV: RR 0.33 [95% CI 0.11-1.02]; SGA vs. BMV: RR 0.50 [95% CI 0.14-1.80]; ETI vs. SGA: RR 0.66 [95% CI 0.18-2.46]) (all very low certainty). In the ranking analysis, the hierarches for efficacy for survival and favorable neurological outcome were BMV > SGA > ETI.
CONCLUSION: Although the available evidence is from observational studies and its certainty is low to very low, prehospital AAM for pediatric OHCA did not improve outcomes.
参考来源
- Amagasa S, Utsumi S, Moriwaki T, et al. Advanced airway management for pediatric out-of-hospital cardiac arrest: A systematic review and network meta-analysis. Am J Emerg Med. 2023. PMID: 37027937. doi:10.1016/j.ajem.2023.03.049
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。